Chemours Co Annual Deferred Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Chemours Co annual Deferred Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • Chemours Co annual Deferred Income Tax Expense (Benefit) for 2023 was -$158M, a 890% decline from 2022.
  • Chemours Co annual Deferred Income Tax Expense (Benefit) for 2022 was $20M.
  • Chemours Co annual Deferred Income Tax Expense (Benefit) for 2021 was -$76M, a 36.7% increase from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$158M -$178M -890% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $20M +$96M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$76M +$44M +36.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-27
2020 -$120M +$43M +26.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$163M -$185M -841% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $22M -$61M -73.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 $83M +$194M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 -$111M +$87M +43.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
2015 -$198M -$176M -800% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 -$22M -$8M -57.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 -$14M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.